Stockreport

Cogent Biosciences FDA Milestones Put Bezuclastinib And Valuation In Focus [Yahoo! Finance]

Cogent Biosciences, Inc.  (COGT) 
Last cogent biosciences, inc. earnings: 11/8 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.cogint.com/investor-relations
PDF Cogent Biosciences received FDA Breakthrough Therapy Designation for bezuclastinib in combination with sunitinib in gastrointestinal stromal tumors (GIST). The FDA al [Read more]